ATE211002T1 - Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen - Google Patents

Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen

Info

Publication number
ATE211002T1
ATE211002T1 AT99920952T AT99920952T ATE211002T1 AT E211002 T1 ATE211002 T1 AT E211002T1 AT 99920952 T AT99920952 T AT 99920952T AT 99920952 T AT99920952 T AT 99920952T AT E211002 T1 ATE211002 T1 AT E211002T1
Authority
AT
Austria
Prior art keywords
mixture containing
surgical adhesions
prevent surgical
dextrine
containing dextrine
Prior art date
Application number
AT99920952T
Other languages
German (de)
English (en)
Inventor
Colin Brown
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810127.2A external-priority patent/GB9810127D0/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Application granted granted Critical
Publication of ATE211002T1 publication Critical patent/ATE211002T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99920952T 1998-05-13 1999-05-13 Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen ATE211002T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810127.2A GB9810127D0 (en) 1998-05-13 1998-05-13 Prevention of surgical adhesions
US27271399A 1999-03-19 1999-03-19
PCT/GB1999/001306 WO1999058168A1 (en) 1998-05-13 1999-05-13 Dextrin-containing composition for preventing surgical adhesions

Publications (1)

Publication Number Publication Date
ATE211002T1 true ATE211002T1 (de) 2002-01-15

Family

ID=26313653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920952T ATE211002T1 (de) 1998-05-13 1999-05-13 Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen

Country Status (16)

Country Link
EP (1) EP1085920B1 (enExample)
JP (2) JP3679710B2 (enExample)
CN (1) CN1181894C (enExample)
AT (1) ATE211002T1 (enExample)
AU (1) AU740832B2 (enExample)
BR (1) BR9911769B8 (enExample)
CA (1) CA2331672C (enExample)
DE (1) DE69900648T2 (enExample)
DK (1) DK1085920T3 (enExample)
ES (1) ES2165735T3 (enExample)
IL (2) IL139283A0 (enExample)
NO (1) NO312709B1 (enExample)
NZ (2) NZ507832A (enExample)
PL (1) PL194109B1 (enExample)
PT (1) PT1085920E (enExample)
WO (1) WO1999058168A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363713A (en) * 2000-06-21 2002-01-09 Ml Lab Plc Dextrin compositions
CA2392666C (en) * 2000-01-21 2011-12-13 Ml Laboratories Plc Dextrin containing compositions for prevention of adhesions
GB0115505D0 (en) * 2001-06-25 2001-08-15 Britannia Pharmaceuticals Ltd Prevention of surgical adhesions
US8252333B2 (en) * 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
US8455001B2 (en) 2007-02-06 2013-06-04 Teijin Limited Cellulose derivative and method for production thereof
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
EP2676682A1 (en) * 2011-02-08 2013-12-25 Jorge Cueto García Thixotropic biological adhesive for use in internal body cavities
US20220265896A1 (en) * 2019-08-01 2022-08-25 Km Biologics Co., Ltd. Tissue fibrosis inhibitor in which biocompatible polymer is used

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207676B1 (en) * 1985-06-22 1994-06-01 M L Laboratories Plc Polymers for use in continuous peritoneal dialysis
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5093319A (en) * 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
EP0426368B1 (en) * 1989-10-31 1995-01-04 Howmedica Inc. Compositions containing derivatives of chitin for preventing adhesion
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5614515A (en) * 1994-11-17 1997-03-25 University Of Southern California Lazaroid-based compositions and method for preventing adhesion formation using the same
US5807833A (en) * 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
CA2223590A1 (en) * 1995-06-07 1996-12-19 The University Of Southern California Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
JP3925955B2 (ja) * 1996-04-26 2007-06-06 株式会社クラレ 癒着防止材
IN192791B (enExample) * 1996-06-28 2004-05-22 Johnson & Johnson Medical

Also Published As

Publication number Publication date
BR9911769B8 (pt) 2021-06-22
JP4276601B2 (ja) 2009-06-10
CA2331672C (en) 2007-02-06
NO20005492L (no) 2001-01-12
BR9911769A (pt) 2001-02-06
ES2165735T3 (es) 2002-03-16
DE69900648D1 (de) 2002-01-31
CN1181894C (zh) 2004-12-29
JP2005047929A (ja) 2005-02-24
EP1085920B1 (en) 2001-12-19
NO20005492D0 (no) 2000-11-01
AU740832B2 (en) 2001-11-15
EP1085920A1 (en) 2001-03-28
CA2331672A1 (en) 1999-11-18
NZ523994A (en) 2004-11-26
NZ507832A (en) 2003-03-28
PL344536A1 (en) 2001-11-05
JP2003528026A (ja) 2003-09-24
HK1034680A1 (en) 2001-11-02
BR9911769B1 (pt) 2014-10-07
PL194109B1 (pl) 2007-04-30
CN1300226A (zh) 2001-06-20
NO312709B1 (no) 2002-06-24
JP3679710B2 (ja) 2005-08-03
IL139283A (en) 2007-02-11
AU3833699A (en) 1999-11-29
DE69900648T2 (de) 2002-07-04
PT1085920E (pt) 2002-06-28
IL139283A0 (en) 2001-11-25
DK1085920T3 (da) 2002-04-15
WO1999058168A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
ATE113636T1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
NO20021013L (no) Vandig geldannet blanding som omfatter en blokk-kopolymer inkluderende minst en vannopplöselig blokk og en hydrofob blokk
MXPA03010448A (es) Metodo y composicion para reducir la union de bacterias a biomateriales.
AR030245A1 (es) Composiciones de gel que contienen metronidazol
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
DE69425433D1 (de) Getränke-stabilisierungssystem
CA2423096A1 (en) Low residue well treatment fluids and methods of use
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
BR9916285A (pt) Processo e composição para reduzir a permeabilidade de uma zona subterrânea
PL332627A1 (en) Application of modified starcg as an agent capable to produce a thermally reversible jelly form of substances
CA2390824A1 (en) Stabilized aqueous acidic antiperspirant compositions and related methods
BR9907679A (pt) Complexo estéril de peptìdio terapêutico ligado a um polissacarìdeo
AU612085B1 (en) Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
AU7040598A (en) Glycosaminoglycans having high antithrombotic activity
ATE211002T1 (de) Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
DE69431162D1 (en) Fenbendazolformulierungen
MXPA05005572A (es) Esteres de acido aldonico, metodos para producir el mismo y metodos para producir ingredientes activos farmaceuticos acoplados a polisacaridos o derivados de polisacaridos en grupos de aminos libres.
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
CA2048055A1 (fr) Composition comportant un polysaccharide obtenu par fermentation microbienne
EP0281131A3 (en) Blends of water soluble polymers
AU4950296A (en) Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
CA2051892A1 (en) Hydrophobically modified carboxyalkyl hydroxyalkyl ethers of polygalactomannans
AU2525601A (en) Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
AU3028900A (en) Ras activator nucleic acid molecules, polypeptides and methods of use
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EEFA Change of the company name